Sensitivity of the cervical transformation zone to estrogen-induced squamous carcinogenesis

Cancer Research

Volumn 60, Issue 5, 2000, Pages 1267-1275

  Elson, David A ^b   Riley, Rebeccah R ^b   Lacey, Ama ^b   Thordarson, Gudmundur ^d   Talamantes, Frank J ^d   Arbeit, Jeffrey M ^a,b,c  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DNA; ESTROGEN; KERATIN;

ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; FEMALE; GENE EXPRESSION; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; MOUSE; NONHUMAN; ONCOGENE; PRIORITY JOURNAL; SQUAMOUS CELL CARCINOMA; UTERINE CERVIX CANCER; WART VIRUS;

ANIMALS; CARCINOMA, SQUAMOUS CELL; CELL TRANSFORMATION, NEOPLASTIC; CERVIX UTERI; DISEASE SUSCEPTIBILITY; ESTROGENS; FEMALE; HUMANS; MICE; NEOPLASMS, HORMONE-DEPENDENT; PAPILLOMAVIRIDAE; PAPILLOMAVIRUS INFECTIONS; TUMOR VIRUS INFECTIONS; UTERINE CERVICAL NEOPLASMS;

EID: 0034163386     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (45)

1. Jordan, J., and Singer, A. The Cervix, pp. 87-104. London: The Whitefriars Press Limited, 1976.
2. Birchmeier, C., Meyer, D., and Riethmacher, D. Factors controlling growth, motility, and morphogenesis of normal and malignant epithelial cells. Int. Rev. Cytol., 160: 221-226, 1995.
3. Kim, R., Weissfeld, J. L., Reynolds, J. C., and Kuller, L. H. Etiology of Barrett's metaplasia and esophageal adenocarcinoma [see comments]. Cancer Epidemiol. Biomark. Prev., 6: 369-377, 1997.
4. Hirota, W. K., Loughney, T. M., Lazas, D. J., Maydonovitch, C. L., Rholl, V., and Wong, R. K. Specialized intestinal metaplasia, dysplasia and cancer of the esophagus and esophagogastric junction: prevalence and clinical data. Gastroenterology, 116: 277-285, 1999.
5. Kuipers, E. J. Review article: relationship between Helicobacter pylori, atrophic gastritis and gastric cancer. Aliment. Pharmacol. Ther., 12 (Suppl. 1): 25-36, 1998.
6. zur Hausen, H. Human papillomavirus in the pathogenesis of anogenital cancer. Virology, 184: 9-13, 1991.
7. De Villers, E. Human pathogenic papillomavirus type: an update. Curr. Top. Microbiol. Immunol., 186: 1-12, 1994.
8. Kinzler, K. W., and Vogelstein, B. Lessons from hereditary colorectal cancer. Cell, 87: 159-170, 1996.
9. Auborn, K., Woodworth, C., DiPaolo, J., and Bradlow, H. The interaction between HPV infection and estrogen metabolism in cervical carcinogenesis. Int. J. Cancer, 49: 867-869, 1990.
10. Arbeit J. Transgenic models of epidermal neoplasia and multi-stage carcinogenesis. Cancer Surv., 26: 7-34, 1996.
11. Coussens, L., Hanahan, D., and Arbeit, J. Genetic susceptibility, alterations in differentiation, and invasion during multi-stage squamous carcinogenesis in K14-HPV16 transgenic mice. Am. J. Pathol., 149: 1899-1917, 1996.
12. Smith-McCune, K., Zhu, Y., Hanahan, D., and Arbeit, J. Cross-species comparison of angiogenesis during the premalignant stages of squamous carcinogenesis in the human cervix and K14-HPV16 transgenic mice. Cancer Res., 57: 1294-1300, 1997.
13. Arbeit J. M., Riley, R. R., Huey, B., Porter, C., Kelloff, G., Lubet, R., Ward, J. M., and Pinkel, D. DFMO chemoprevention of epidermal carcinogenesis in K14-HPV16 transgenic mice. Cancer Res., 59: 3610-3620, 1999.
14. Arbeit, J., Howley, P., and Hanahan, D. Chronic estrogen induced cervical and vaginal squamous carcinogenesis in HPV16 transgenic mice. Proc. Natl. Acad. Sci. USA, 91: 2930-2935, 1996.
15. Arbeit, J., Münger, K., Howley, P., and Hanahan, D. Progressive squamous epithelial neoplasia in K14-human papillomavims type 16 transgenic mice. J. Virol., 68: 4358-4368, 1994.
16. Christov, K., Guzman, R., Swanson, S., Thordarson, G., Talamantes, F., and Nandi, S. Cell proliferation and apoptosis during mammary carcinogenesis in pituitary isografted mice. Carcinogenesis (Lond.), 17: 1741-1746, 1996.
17. Arbeit, J., Olson, D., and Hanahan, D. Upregulation of fibroblast growth factors and their receptors during multi-stage epidermal carrinogenesis in K14-HPV16 transgenic mice. Oncogene, 13: 1847-1857, 1996.
18. Katovich, M., and O'Meara, J. Effect of chronic estrogen on the skin temperature response to naloxone in morphine-dependent rats. Can. J. Pharmacol., 65: 563-567, 1987.
19. Lubahn, D., Moyer, J., Golding, T., Couse, J., Korach, K., and Smithies, O. Alterations of reproductive tract function but not prenatal sexual development after insertional disruption of the mouse estrogen receptor gene. Proc. Natl. Acad. Sci. USA, 90: 11162-11166, 1993.
20. Korach, K. Insights from the study of animals lacking functional estrogen receptor. Science (Washington DC), 266: 1524-1527, 1994.
21. Jones, L., and Bern, H. Cervicovaginal and mammary gland abnormalities in BALB/cCrgl mice treated neonatally with progesterone and estrogen, alone or in combination. Cancer Res., 39: 2560-2567, 1979.
22. Silver, L. Mouse Genetics: Concepts and Applications, pp. 44-52. New York: Oxford University Press, 1995.
23. Lavigne, J., Helzlsouer, K., Huang, H., Strickland, P., Bell, D., Selmin, O., Watson, M., Hoffman, S., Comstock, G., and Yager, J. An association between the allele coding for a low activity variant of catechol-O-methyltransferase and the risk for breast cancer. Cancer Res., 57: 5493-5497, 1997.
24. Thompson, P., Shields, P., Freudenheim, J., Stone, A., Vena, J., Marshall, J., Graham, S., Laughlin, R., Nemoto, T., Kadlubar, F., and Ambrosone, C. Genetic polymorphisms in catechol-O-methlytransferase, menopausal status, and breast cancer risk. Cancer Res., 58: 2107-2110, 1998.
25. Swaneck, G., and Fishman, J. Covalent binding of the endogenous estrogen 16α-hydroxyestrone to estradiol receptor in human breast cancer cells: characterization and intranuclear localization. Proc. Natl. Acad. Sci. USA, 85: 7831-7835, 1988.
26. Fotsis, T., Zhang, Y., Pepper, M., Adlercreutz, H., Montesano, R., Nawroth, P., and Schweigerer, L. The endogenous oestrogen metabolite 2-methoxyestradiol inhibits angiogenesis and suppresses tumour growth. Nature (Lond.), 368: 237-239, 1994.
27. Hennings, H., Glick, A., Lowry, D., Krsmanovic, L., Sly, L., and Yuspa, S. FVB/n mice: an inbred strain sensitive to the chemical induction of squamous cell carcinomas in the skin. Carcinogenesis (Lond.), 14: 2353-2358, 1993.
28. Ivanyi, D., Groeneveld, E., Van Doornewaard. G., Mooi, W. J., and Hageman, P. C. Keratin subtypes in carcinomas of the uterine cervix: implications for histogenesis and differential diagnosis. Cancer Res., 50: 5143-5152, 1990.
29. Smedts, F., Ramaekers, F., Troyanovsky, S., Pruszczynski, M., Robben, H., Lane, B., Leigh, I., Plantema, F., and Vooijs, P. Basal-cell keratins in cervical reserve cells and a comparison to their expression in cervical intraepithelial neoplasia. Am. J. Pathol., 140: 601-612, 1992.
30. Vooijs, G. P. The problem of replacement and differentiation of the intestinal epithelium: its relation to squamous metaplasia in the uterine cervix. Cancer (Phila.), 81: 317-322, 1997.
31. Tsutsumi, K., Sun, Q., Yasumoto, S., Kikuchi, K., Ohta, Y., Pater, A., and Pater, M. In vitro and in vivo analysis of cellular origin of cervical squamous metaplasia. Am. J. Pathol., 143: 1150-1158, 1993.
32. Tong, X., and Howley, P. The bovine papillomavirus E6 oncoprotein interacts with paxillin and disrupts the actin cytoskeleton. Proc. Natl. Acad. Sci. USA, 94: 4412-4417, 1997.
33. Reid, B. L., Singer, A., and Coppleson, M. The process of cervical regeneration after electrocauterization. 1. Histological and colposcopic study. Aust, N. Z. J. Obstet. Gynaecol., 7: 125-135, 1967.
34. Zwerschke, W., Mazurek, S., Massimi, P., Banks, L., Eigenbrodt E., and Jansen-Durr, P. Modulation of type M2 pyruvate kinase activity by the human papillomavirus type 16 E7 oncoprotein. Proc. Natl. Acad. Sci. USA, 96: 1291-1296, 1999.
35. Chellappan, S., Kraus, V., Kroger, B., Münger, K., Howley, P., Phelps, W., and Nevins, J. R. Adenovirus E1A, simian virus 40 tumor antigen, and human papillomavirus E7 protein share the capacity to disrupt the interaction between the transcription factor E2F and the retinoblastoma gene product. Proc. Natl. Acad. Sci. USA, 89: 4549-4553, 1992.
36. O'Malley, B. W., Schrader, W. T., Mani, S., Smith, C., Weigel, N. L., Conneely, O. M., and Clark, J. H. An alternative ligand-independent pathway for activation of steroid receptors. Recent Prog. Horm. Res., 50: 333-347, 1995.
37. Weigel, N. L., and Zhang, Y. Ligand-independent activation of steroid hormone receptors [see comments]. J. Mol. Med., 76: 469-479, 1998.
38. Straight, S., Hinkle, P., Jewers, R., and McCance, D. The E5 oncoprotein of human papillomavirus type 16 transforms fibroblasts and effects the downregulation of the epidermal growth factor receptor on keratinocytes. J. Virol., 67: 4521-4532, 1993.
39. Bunone, G., Briand, P.A., Miksicek, R. J., and Picard, D. Activation of the unliganded estrogen receptor by EGF involves the MAP kinase pathway and direct phosphorylation. EMBO J., 15: 2174-2183, 1996.
40. Xu, L., Glass, C., and Rosenfeld, M. Coactivator and corepressor complexes in nuclear receptor function. Curr. Opin. Genet. Dev., 9: 140-147, 1999.
41. Magnaghi-Jaulin, L., Groisman, R., Naguibneva, I., Robin, P., Lorain, S., Le Villain, J. P., Troalen, F., Trouche, D., and Harel-Bellan, A. Retinoblastoma protein represses transcription by recruiting a histone deacetylase [see comments]. Nature (Lond.), 391: 601-605, 1998.
42. Brehm, A., Miska, E. A., McCance, D. J., Reid, J. L. Bannister, A. J., and Kouzarides, T. Retinoblastoma protein recruits histone deacetylase to repress transcription [see comments]. Nature (Lond.), 391: 597-601, 1998.
43. Ghahary, A., Chakrabarti, S., and Murphy, L. Localization of the sites of synthesis and action of insulin-like growth factor-1 in the rat uterus. Mol. Endocrinol., 4: 191-195, 1990.
44. Scheffner, M., Romanchuk, H., Münger, K., Huibregtse, J., Mietz, J., and Howley, P. Functions of human papillomavirus proteins. Curr. Top. Microbiol. Immunol., 186: 83-99, 1994.
45. Galloway, D., Derners, G., Foster, S., Halbert, C., and Russell, K. Cell cycle checkpoint control is bypasses by human papillomavirus oncogenes. Cold Spring Harbor Symp. Quant. Biol., 59: 297-306, 1994.